Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 1/20 | 0.56 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2036076 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL9009685 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL3313685 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL11055261 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL1019696 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL1022263 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL448507 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL16610539 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL21428081 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| SCHEMBL1337956 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118342701-A | Low-defect polishing pad and preparation method thereof | 万华化学集团电子材料有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-114011585-B | Flotation method for fine-grained collophanite in gravity tailings | 宜都兴发化工有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117303754-B | Glass fiber antistatic impregnating compound and preparation method thereof | 清远忠信世纪电子材料有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-117303753-B | Low-mobility impregnating compound and preparation method and application thereof | 清远忠信电子材料有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-117303753-A | Low-mobility impregnating compound and preparation method and application thereof | 清远忠信电子材料有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117303754-A | Glass fiber antistatic impregnating compound and preparation method thereof | 清远忠信世纪电子材料有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-116689157-A | Anion-cation combined collector and application thereof in floatation andalusite | 辽宁大学 | 2023-09-05 | — | — | CN | claimed |
| CN-116061101-A | Treatment method of polymer microsphere for polishing pad | 万华化学集团电子材料有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-115999479-A | Production system and preparation method for continuously producing salt-free amphoteric surfactant | 岳阳科罗德联合化学工业有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-113072046-B | Method for removing impurities and improving whiteness of phosphogypsum through flotation method | 郑州大学 | 2022-06-17 | — | — | CN | claimed |
| US-8697616-B2 | Organic molybdenum additive, its preparation method, a lubricating composition containing said additive, and use of the same | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2014-04-15 | — | — | US | claimed |
| CN-103301950-A | Combined cationic collector for reverse flotation desilication of hematite stone | UNIV NORTHEASTERN | 2013-09-18 | — | — | CN | claimed |
| CN-102188928-A | Fluorocarbon cationic gemini and hybridized gemini surfactants and synthesis method thereof | CHENGDU ORGANIC CHEMICALS CO | 2011-09-21 | — | — | CN | claimed |
| US-20090156443-A1 | ORGANIC MOLYBDENUM ADDITIVE, ITS PREPARATION METHOD, A LUBRICATING COMPOSITION CONTAINING SAID ADDITIVE, AND USE OF THE SAME | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2009-06-18 | — | — | US | claimed |
| EP-1992676-A1 | ORGANOMOLYBDENUM ADDITIVE, ITS PREPARATION AND LUBRICATING COMPOSITION CONTAINING THE ADDITIVE AND USES THEREOF | China Petroleum & Chemical Corporation (CN) | 2008-11-19 | — | — | EP | claimed |
| EP-1511828-A4 | EMULSIFICATION OF LANOLIN | SUPREME PROTECTOR IRELAND LTD (IE) | 2006-03-15 | — | — | EP | claimed |
| US-20050203182-A1 | Emulsification of lanolin | SUPREME PROTECTOR IRELAND LTD. (IE) | 2005-09-15 | — | — | US | claimed |
| EP-1511828-A1 | EMULSIFICATION OF LANOLIN | Supreme Protector Ireland Ltd. (IE) | 2005-03-09 | — | — | EP | claimed |
| WO-2003097775-A1 | EMULSIFICATION OF LANOLIN | SUPREME PROTECTOR IRELAND LTD. (IE) | 2003-11-27 | — | — | WO | claimed |
| US-4172046-A | Emulsifier composition for asphalt emulsion | KAO SOAP CO., LTD. (JP) | 1979-10-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156443-A1 | ORGANIC MOLYBDENUM ADDITIVE, ITS PREPARATION METHOD, A LUBRICATING COMPOSITION CONTAINING SAID ADDITIVE, AND USE OF THE SAME | PUF60, ELOVL5, ALOX5 | PLA2G1B 1090/4885PLA2G2A 2965/4885OPRM1 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.